Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.







APA-OTS-Meldungen aus dem Finanzsektor in der "BSN Extended Version"
Wichtige Originaltextaussendungen aus der Branche. Wir ergänzen vollautomatisch Bilder aus dem Fundus von photaq.com und Aktieninformationen aus dem Börse Social Network. Wer eine Korrektur zu den Beiträgen wünscht: mailto:office@boerse-social.com . Wir wiederum übernehmen keinerlei Haftung für Augenerkrankungen aufgrund von geballtem Grossbuchstabeneinsatz der Aussender. Wir meinen: Firmennamen, die länger als drei Buchstaben sind, schreibt man nicht durchgängig in Grossbuchstaben (Versalien).
Magazine aktuell


#gabb aktuell



08.10.2020, 9595 Zeichen

Corporate news transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.
Forecast: EBIT at least matching prior-year level
Mid Year Results
Vienna - AGRANA, the fruit, starch and sugar company, generated operating profit (EBIT) of EUR 55.8 million in the first half of the 2020|21 financial year, a moderate increase of 7.9% year-on-year (H1 prior year: EUR 51.7 million). The Group's revenue rose slightly to EUR 1,309.3 million (H1 prior year: EUR 1,250.0 million).
AGRANA Chief Executive Officer Johann Marihart says: "Much of our positive business performance can be credited to the diversification of our business activities, which enables us to balance out fluctuating economic conditions in the various segments. Thus, in the first half of the year, the Starch segment was able to maintain the prior year's EBIT earnings despite significantly weaker starch sales in the paper sector, thanks to the very strong performance in bioethanol especially in the second quarter."
Helping make the year-on-year growth in Group EBIT possible was the Sugar segment, which, as in the first quarter, saw a year-on-year improvement in earnings in the second quarter as a result of higher sugar prices. The Sugar segment's EBIT nonetheless remained negative. In the Fruit segment, AGRANA was able to hold earnings in the fruit preparations business in line with the first half of the prior year. The performance of the fruit juice concentrate business was down significantly due to lower available volumes from the 2019 apple crop.
AGRANA Group consolidated financial results EUR million, except %
H1 2020|21 H1 2019|20 Revenue 1,309.3 1,250.0 EBITDA* 101.1 90.8 Operating profit** 47.7 44.0 Share of results of equity-accounted joint ventures 8.9 7.7 Exceptional items (0.5) 0.0 Operating profit (EBIT) 55.8 51.7 Net financial items 4.3% 4.1% Profit for the period 34.4 28.9 Investment*** 27.8 68.1

Q2 2020|21 Q2 2019|20 Revenue 656.7 611.6 EBITDA* 46.4 39.3 Operating profit** 19.3 16.5 Share of results of equity-accounted joint ventures 5.0 4.3 Exceptional items (0.5) 0.0 Operating profit (EBIT) 23.8 20.8 EBIT margin 3.6% 3.4% Profit for the period 15.2 10.6 Investment*** 16.7 34.5

* EBITDA represents operating profit before exceptional items, results of equity-accounted joint ventures, and operating depreciation and amortisation ** Operating profit before exceptional items and results of equity-accounted joint ventures *** Investment represents purchases of property, plant and equipment and intangible assets, excluding goodwill
Net financial items amounted to an expense of EUR 9.1 million (H1 prior year: expense of EUR 7.9 million). After an income tax expense of EUR 12.3 million, corresponding to a tax rate of about 26.3% (H1 prior year: 34.0%), profit for the period was EUR 34.4 million (H1 prior year: EUR 28.9 million). Earnings per share attributable to AGRANA shareholders increased to EUR 0.54 (H1 prior year: EUR 0.43).
Net debt at 31 August 2020 amounted to EUR 479.6 million, up EUR 15.6 million from the year-end level of 29 February 2020 (year-ago level of 31 August 2019: EUR 423.6 million). The gearing ratio rose accordingly to 36.1% as of the quarterly balance sheet date (29 February 2020: 33.5%; 31 August 2019: 31.2%).
Fruit segment EUR million, except %
H1 2020|21 H1 2019|20 Revenue 601.8 595.6 Operating profit (EBIT) 30.1 36.1 EBIT margin 5.0% 6.1%

Q2 2020|21 Q2 2019|20 Revenue 298.1 284.1 Operating profit (EBIT) 14.1 14.3 EBIT margin .7% 5.0%

The Fruit segment's revenue in the first half of 2020|21 rose slightly year-on- year, by 1.0%. In the fruit preparations business, revenue remained stable despite somewhat lower sales volumes. Revenue in the fruit juice concentrate activities saw an increase from a year ago, thanks largely to higher prices for apple juice concentrate produced from the 2019 crop. EBIT of the Fruit segment was off 16.6% from the first half of 2019|20. The reason for the deterioration lay in lower delivery volumes in the fruit juice concentrate business combined with reduced contribution margins for apple juice concentrate from the 2019 harvest.
Starch segment EUR million, except %
H1 2020|21 H1 2019|20 Revenue 407.2 407.8 Operating profit (EBIT) 34.7 34.3 EBIT margin 8.5% 8.4%

Q2 2020|21 Q2 2019|20 Revenue 202.8 200.1 Operating profit (EBIT) 17.7 15.9 EBIT margin 8.7% 7.9%

Starch segment revenue in the first half of 2020|21 was steady at the prior-year level. With the full operation of the new, second wheat starch plant, sales volumes and revenues of the products manufactured in-house increased. At the same time, revenue from resold merchandise declined sharply, as the sale of sugar by-products is now charged on a commission basis and the corresponding sales are no longer included in the Starch segment's revenue. Ethanol quotations, after collapsing in March 2020 amid the COVID-19 lockdown and the steep fall in demand for petrol, recovered again progressively especially in the second financial quarter and even reached a new all-time high in August. Sales volumes of saccharification products, on the other hand, were negatively affected by the COVID-19 crisis, particularly with the beverage industry.
EBIT in the Starch segment slightly exceeded the year-earlier result, by 1.2%. The earnings were driven by the high selling prices for ethanol, which made up for the lower market demand for starch and starch products.
Sugar segment EUR million, except %
H1 2020|21 H1 2019|20 Revenue 300.3 246.6 Operating profit (EBIT) (9.0) (18.7) EBIT margin (3.0%) (7.6%)

Q2 2020|21 Q2 2019|20 Revenue 155.8 127.4 Operating profit (EBIT) (8.0) (9.4) EBIT margin (5.1%) (7.4%)

The Sugar segment's revenue in the first half of 2020|21 was up 21.8% from one year earlier. This growth was attributable both to higher sugar selling prices and increased sugar sales volumes, especially with food retailers. Although EBIT was still negative, it marked a substantial improvement from the same period of the prior year due to a more benign sales price environment.
Outlook
Taking into account potential impacts of the coronavirus crisis, AGRANA expects Group EBIT for the full 2020|21 financial year to at least match the prior-year level. Group revenue is projected to show slight to moderate growth of up to 10%. Due to the ongoing COVID-19 pandemic and the associated high volatility in all business segments, this forecast remains characterised by a very high degree of uncertainty. It also does not yet include any financial effects of a possible closure of the sugar plant in Leopoldsdorf, Austria, after the 2020 campaign.
The drive to secure grower contracts with beet farmers is underway, with the aim of increasing next year's beet cultivation area in Austria to at least 38,000 hectares by the middle of November 2020. With a three-year contract and guaranteed minimum prices, AGRANA is offering farmers long-term predictability for beet cultivation. Depending on the contracting status in mid-November, a decision will be made on whether to continue operations at the Leopoldsdorf factory or close it down after the end of the campaign.
In the 2020|21 financial year, the AGRANA Group's investment is expected to amount to EUR 73 million, which is significantly below the year's depreciation of about EUR 120 million following the very high capital expenditure of prior years.
About AGRANA
AGRANA converts agricultural raw materials into high-quality foods and numerous industrial intermediate products. About 9,400 employees at 56 production sites worldwide generate annual Group revenue of approximately EUR 2.5 billion. Established in 1988, the company is the world market leader in fruit preparations and the foremost producer of fruit juice concentrates in Europe. As well, its Starch segment is a major manufacturer of custom starch products and of bioethanol. AGRANA today is also the leading sugar producer in Central and Eastern Europe.
This announcement is available in German and English at www.agrana.com [https:// www.agrana.com/en]
end of announcement euro adhoc
issuer: AGRANA Beteiligungs-AG F.-W.-Raiffeisen-Platz 1 A-1020 Wien phone: +43-1-21137-0 FAX: +43-1-21137-12926 mail: info.ab@agrana.com WWW: www.agrana.com ISIN: AT000AGRANA3 indexes: WBI stockmarkets: Frankfurt, Berlin, Wien, Stuttgart language: English
Digital press kit: http://www.ots.at/pressemappe/4/aom

BSN Podcasts
Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #796: ATX stärker und Tons of News sowie ein Reinhören in einen neuen Weihnachtssong von uns




Agrana
Akt. Indikation:  10.75 / 10.90
Uhrzeit:  22:58:35
Veränderung zu letztem SK:  -0.23%
Letzter SK:  10.85 ( 0.93%)



 

Bildnachweis

1. Agrana-Firmenschilder im Raiffeisen-Haus 1020 Wien, 5.7.19   >> Öffnen auf photaq.com

Aktien auf dem Radar:Pierer Mobility, Porr, Austriacard Holdings AG, Immofinanz, CA Immo, Wienerberger, Frequentis, Erste Group, Bawag, Uniqa, RBI, Andritz, UBM, Cleen Energy, Gurktaler AG Stamm, Wolford, Zumtobel, Marinomed Biotech, Oberbank AG Stamm, Kapsch TrafficCom, Agrana, Amag, EVN, Flughafen Wien, OMV, Palfinger, Österreichische Post, Telekom Austria, VIG.


Random Partner

Evotec
Evotec ist ein Wirkstoffforschungs- und -entwicklungsunternehmen, das in Forschungsallianzen und Entwicklungspartnerschaften mit Pharma- und Biotechnologieunternehmen, akademischen Einrichtungen, Patientenorganisationen und Risikokapitalgesellschaften Ansätze zur Entwicklung neuer pharmazeutischer Produkte vorantreibt.

>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner


Mehr aktuelle OTS-Meldungen HIER

Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten


Meistgelesen
>> mehr





PIR-Zeichnungsprodukte
AT0000A2QMD1
AT0000A3C5R2
AT0000A36XA1
Newsflow
>> mehr

Börse Social Club Board
>> mehr
    wikifolio-Trades Austro-Aktien 22-23: OMV(1)
    wikifolio-Trades Austro-Aktien 18-19: RBI(1)
    Star der Stunde: Kapsch TrafficCom 1.47%, Rutsch der Stunde: Warimpex -6.67%
    wikifolio-Trades Austro-Aktien 17-18: RBI(3), OMV(1), Kontron(1)
    Star der Stunde: Pierer Mobility 1.14%, Rutsch der Stunde: Warimpex -6.67%
    wikifolio-Trades Austro-Aktien 16-17: Immofinanz(1)
    Star der Stunde: Lenzing 0.9%, Rutsch der Stunde: Warimpex -6.67%
    wikifolio-Trades Austro-Aktien 15-16: Kontron(2), SBO(1), EVN(1)
    BSN MA-Event Frequentis

    Featured Partner Video

    Börsepeople im Podcast S15/20: Oliver Olbrich

    Oliver Olbrich ("Double O, "the one and only") und ich kennen uns seit einem halben Leben aus dem Mediengeschäft und jetzt wollen wir alle Börsepeople die mitmachen wollen, digitalisieren. Diese Fo...

    Books josefchladek.com

    Max Zerrahn
    Musical Chairs
    2024
    White Belt Publishing

    Kjell-Ake Andersson & Mikael Wiström
    Gruvarbetare i Wales
    1977
    Trydells

    Dominic Turner
    False friends
    2023
    Self published

    Yasuhiro Ishimoto
    Ishimoto 石元 泰博
    2024
    Editions Xavier Barral / LE BAL

    Nikita Teryoshin
    Nothing Personal
    2024
    GOST

    Results for the first half of 2020|21 (ended 31 August 2020) - AGRANA boosts EBIT and revenue


    08.10.2020, 9595 Zeichen

    Corporate news transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.
    Forecast: EBIT at least matching prior-year level
    Mid Year Results
    Vienna - AGRANA, the fruit, starch and sugar company, generated operating profit (EBIT) of EUR 55.8 million in the first half of the 2020|21 financial year, a moderate increase of 7.9% year-on-year (H1 prior year: EUR 51.7 million). The Group's revenue rose slightly to EUR 1,309.3 million (H1 prior year: EUR 1,250.0 million).
    AGRANA Chief Executive Officer Johann Marihart says: "Much of our positive business performance can be credited to the diversification of our business activities, which enables us to balance out fluctuating economic conditions in the various segments. Thus, in the first half of the year, the Starch segment was able to maintain the prior year's EBIT earnings despite significantly weaker starch sales in the paper sector, thanks to the very strong performance in bioethanol especially in the second quarter."
    Helping make the year-on-year growth in Group EBIT possible was the Sugar segment, which, as in the first quarter, saw a year-on-year improvement in earnings in the second quarter as a result of higher sugar prices. The Sugar segment's EBIT nonetheless remained negative. In the Fruit segment, AGRANA was able to hold earnings in the fruit preparations business in line with the first half of the prior year. The performance of the fruit juice concentrate business was down significantly due to lower available volumes from the 2019 apple crop.
    AGRANA Group consolidated financial results EUR million, except %
    H1 2020|21 H1 2019|20 Revenue 1,309.3 1,250.0 EBITDA* 101.1 90.8 Operating profit** 47.7 44.0 Share of results of equity-accounted joint ventures 8.9 7.7 Exceptional items (0.5) 0.0 Operating profit (EBIT) 55.8 51.7 Net financial items 4.3% 4.1% Profit for the period 34.4 28.9 Investment*** 27.8 68.1

    Q2 2020|21 Q2 2019|20 Revenue 656.7 611.6 EBITDA* 46.4 39.3 Operating profit** 19.3 16.5 Share of results of equity-accounted joint ventures 5.0 4.3 Exceptional items (0.5) 0.0 Operating profit (EBIT) 23.8 20.8 EBIT margin 3.6% 3.4% Profit for the period 15.2 10.6 Investment*** 16.7 34.5

    * EBITDA represents operating profit before exceptional items, results of equity-accounted joint ventures, and operating depreciation and amortisation ** Operating profit before exceptional items and results of equity-accounted joint ventures *** Investment represents purchases of property, plant and equipment and intangible assets, excluding goodwill
    Net financial items amounted to an expense of EUR 9.1 million (H1 prior year: expense of EUR 7.9 million). After an income tax expense of EUR 12.3 million, corresponding to a tax rate of about 26.3% (H1 prior year: 34.0%), profit for the period was EUR 34.4 million (H1 prior year: EUR 28.9 million). Earnings per share attributable to AGRANA shareholders increased to EUR 0.54 (H1 prior year: EUR 0.43).
    Net debt at 31 August 2020 amounted to EUR 479.6 million, up EUR 15.6 million from the year-end level of 29 February 2020 (year-ago level of 31 August 2019: EUR 423.6 million). The gearing ratio rose accordingly to 36.1% as of the quarterly balance sheet date (29 February 2020: 33.5%; 31 August 2019: 31.2%).
    Fruit segment EUR million, except %
    H1 2020|21 H1 2019|20 Revenue 601.8 595.6 Operating profit (EBIT) 30.1 36.1 EBIT margin 5.0% 6.1%

    Q2 2020|21 Q2 2019|20 Revenue 298.1 284.1 Operating profit (EBIT) 14.1 14.3 EBIT margin .7% 5.0%

    The Fruit segment's revenue in the first half of 2020|21 rose slightly year-on- year, by 1.0%. In the fruit preparations business, revenue remained stable despite somewhat lower sales volumes. Revenue in the fruit juice concentrate activities saw an increase from a year ago, thanks largely to higher prices for apple juice concentrate produced from the 2019 crop. EBIT of the Fruit segment was off 16.6% from the first half of 2019|20. The reason for the deterioration lay in lower delivery volumes in the fruit juice concentrate business combined with reduced contribution margins for apple juice concentrate from the 2019 harvest.
    Starch segment EUR million, except %
    H1 2020|21 H1 2019|20 Revenue 407.2 407.8 Operating profit (EBIT) 34.7 34.3 EBIT margin 8.5% 8.4%

    Q2 2020|21 Q2 2019|20 Revenue 202.8 200.1 Operating profit (EBIT) 17.7 15.9 EBIT margin 8.7% 7.9%

    Starch segment revenue in the first half of 2020|21 was steady at the prior-year level. With the full operation of the new, second wheat starch plant, sales volumes and revenues of the products manufactured in-house increased. At the same time, revenue from resold merchandise declined sharply, as the sale of sugar by-products is now charged on a commission basis and the corresponding sales are no longer included in the Starch segment's revenue. Ethanol quotations, after collapsing in March 2020 amid the COVID-19 lockdown and the steep fall in demand for petrol, recovered again progressively especially in the second financial quarter and even reached a new all-time high in August. Sales volumes of saccharification products, on the other hand, were negatively affected by the COVID-19 crisis, particularly with the beverage industry.
    EBIT in the Starch segment slightly exceeded the year-earlier result, by 1.2%. The earnings were driven by the high selling prices for ethanol, which made up for the lower market demand for starch and starch products.
    Sugar segment EUR million, except %
    H1 2020|21 H1 2019|20 Revenue 300.3 246.6 Operating profit (EBIT) (9.0) (18.7) EBIT margin (3.0%) (7.6%)

    Q2 2020|21 Q2 2019|20 Revenue 155.8 127.4 Operating profit (EBIT) (8.0) (9.4) EBIT margin (5.1%) (7.4%)

    The Sugar segment's revenue in the first half of 2020|21 was up 21.8% from one year earlier. This growth was attributable both to higher sugar selling prices and increased sugar sales volumes, especially with food retailers. Although EBIT was still negative, it marked a substantial improvement from the same period of the prior year due to a more benign sales price environment.
    Outlook
    Taking into account potential impacts of the coronavirus crisis, AGRANA expects Group EBIT for the full 2020|21 financial year to at least match the prior-year level. Group revenue is projected to show slight to moderate growth of up to 10%. Due to the ongoing COVID-19 pandemic and the associated high volatility in all business segments, this forecast remains characterised by a very high degree of uncertainty. It also does not yet include any financial effects of a possible closure of the sugar plant in Leopoldsdorf, Austria, after the 2020 campaign.
    The drive to secure grower contracts with beet farmers is underway, with the aim of increasing next year's beet cultivation area in Austria to at least 38,000 hectares by the middle of November 2020. With a three-year contract and guaranteed minimum prices, AGRANA is offering farmers long-term predictability for beet cultivation. Depending on the contracting status in mid-November, a decision will be made on whether to continue operations at the Leopoldsdorf factory or close it down after the end of the campaign.
    In the 2020|21 financial year, the AGRANA Group's investment is expected to amount to EUR 73 million, which is significantly below the year's depreciation of about EUR 120 million following the very high capital expenditure of prior years.
    About AGRANA
    AGRANA converts agricultural raw materials into high-quality foods and numerous industrial intermediate products. About 9,400 employees at 56 production sites worldwide generate annual Group revenue of approximately EUR 2.5 billion. Established in 1988, the company is the world market leader in fruit preparations and the foremost producer of fruit juice concentrates in Europe. As well, its Starch segment is a major manufacturer of custom starch products and of bioethanol. AGRANA today is also the leading sugar producer in Central and Eastern Europe.
    This announcement is available in German and English at www.agrana.com [https:// www.agrana.com/en]
    end of announcement euro adhoc
    issuer: AGRANA Beteiligungs-AG F.-W.-Raiffeisen-Platz 1 A-1020 Wien phone: +43-1-21137-0 FAX: +43-1-21137-12926 mail: info.ab@agrana.com WWW: www.agrana.com ISIN: AT000AGRANA3 indexes: WBI stockmarkets: Frankfurt, Berlin, Wien, Stuttgart language: English
    Digital press kit: http://www.ots.at/pressemappe/4/aom

    BSN Podcasts
    Christian Drastil: Wiener Börse Plausch

    Wiener Börse Party #796: ATX stärker und Tons of News sowie ein Reinhören in einen neuen Weihnachtssong von uns




    Agrana
    Akt. Indikation:  10.75 / 10.90
    Uhrzeit:  22:58:35
    Veränderung zu letztem SK:  -0.23%
    Letzter SK:  10.85 ( 0.93%)



     

    Bildnachweis

    1. Agrana-Firmenschilder im Raiffeisen-Haus 1020 Wien, 5.7.19   >> Öffnen auf photaq.com

    Aktien auf dem Radar:Pierer Mobility, Porr, Austriacard Holdings AG, Immofinanz, CA Immo, Wienerberger, Frequentis, Erste Group, Bawag, Uniqa, RBI, Andritz, UBM, Cleen Energy, Gurktaler AG Stamm, Wolford, Zumtobel, Marinomed Biotech, Oberbank AG Stamm, Kapsch TrafficCom, Agrana, Amag, EVN, Flughafen Wien, OMV, Palfinger, Österreichische Post, Telekom Austria, VIG.


    Random Partner

    Evotec
    Evotec ist ein Wirkstoffforschungs- und -entwicklungsunternehmen, das in Forschungsallianzen und Entwicklungspartnerschaften mit Pharma- und Biotechnologieunternehmen, akademischen Einrichtungen, Patientenorganisationen und Risikokapitalgesellschaften Ansätze zur Entwicklung neuer pharmazeutischer Produkte vorantreibt.

    >> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner


    Mehr aktuelle OTS-Meldungen HIER

    Useletter

    Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

    Newsletter abonnieren

    Runplugged

    Infos über neue Financial Literacy Audio Files für die Runplugged App
    (kostenfrei downloaden über http://runplugged.com/spreadit)

    per Newsletter erhalten


    Meistgelesen
    >> mehr





    PIR-Zeichnungsprodukte
    AT0000A2QMD1
    AT0000A3C5R2
    AT0000A36XA1
    Newsflow
    >> mehr

    Börse Social Club Board
    >> mehr
      wikifolio-Trades Austro-Aktien 22-23: OMV(1)
      wikifolio-Trades Austro-Aktien 18-19: RBI(1)
      Star der Stunde: Kapsch TrafficCom 1.47%, Rutsch der Stunde: Warimpex -6.67%
      wikifolio-Trades Austro-Aktien 17-18: RBI(3), OMV(1), Kontron(1)
      Star der Stunde: Pierer Mobility 1.14%, Rutsch der Stunde: Warimpex -6.67%
      wikifolio-Trades Austro-Aktien 16-17: Immofinanz(1)
      Star der Stunde: Lenzing 0.9%, Rutsch der Stunde: Warimpex -6.67%
      wikifolio-Trades Austro-Aktien 15-16: Kontron(2), SBO(1), EVN(1)
      BSN MA-Event Frequentis

      Featured Partner Video

      Börsepeople im Podcast S15/20: Oliver Olbrich

      Oliver Olbrich ("Double O, "the one and only") und ich kennen uns seit einem halben Leben aus dem Mediengeschäft und jetzt wollen wir alle Börsepeople die mitmachen wollen, digitalisieren. Diese Fo...

      Books josefchladek.com

      Matthew Genitempo
      Dogbreath
      2024
      Trespasser

      Yasuhiro Ishimoto
      Ishimoto 石元 泰博
      2024
      Editions Xavier Barral / LE BAL

      Daido Moriyama
      Record (Kiroku) No.1-5 (Reprint Edition) 森山 大道 記録
      2008
      Akio Nagasawa

      Kjell-Ake Andersson & Mikael Wiström
      Gruvarbetare i Wales
      1977
      Trydells

      Max Zerrahn
      Musical Chairs
      2024
      White Belt Publishing